WealthCollab’s Gilead Sciences GILD Stock Holding History

WealthCollab’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.6K	Hold	327	–	–	0.02%	218
2025 Q4	$40.1K	Hold	327	–	–	0.02%	251
2025 Q3	$36.3K	Hold	327	–	–	0.02%	241
2025 Q2	$36.3K	Hold	327	–	–	0.02%	221
2025 Q1	$36.6K	Buy	327 +4	+1%	+$413	0.02%	206
2024 Q4	$29.8K	Hold	323	–	–	0.02%	238
2024 Q3	$27.1K	Sell	323 -56	-15%	-$4.27K	0.02%	260
2024 Q2	$26K	Sell	379 -75	-17%	-$5K	0.02%	248
2024 Q1	$33.3K	Hold	454	–	–	0.02%	203
2023 Q4	$36.8K	Buy	+454	New	+$35.3K	0.03%	164

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WealthCollab's GILD Position: Q1 2026 in Review

WealthCollab held its Gilead Sciences (GILD) position steady in Q1 2026 at 327 shares worth $45.6K. The position accounts for 0.02% of the portfolio, ranked #218.

WealthCollab first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

WealthCollab held 327 shares of Gilead Sciences worth $45.6K as of Q1 2026.
WealthCollab left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.02% of WealthCollab's portfolio in Q1 2026, its #218 holding.
WealthCollab first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.